Haleon HLN
NYSE HLN
$9.87 +0.00 (+0.00%)
As of: Aug 20, 2026 · 3:59 PM EDT

Haleon (HLN) Net Cash Flow Growth (3y) (2025)

Haleon (HLN) Net Cash Flow Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -28.90%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -5.41%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 19.55%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 95.24%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -106.21%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 4.40%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 17.73%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn -22.55%

Historic Data

Download Data
DateValue
Dec 31, 2025 31.59%